These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8328582)

  • 21. An open multicentre study to evaluate the efficacy and tolerance of fluoxetine 20 mg in depressed ambulatory patients.
    Mesters P; Ansseau M; Brasseur R; Bussios G; Cosyns P; Czarka M; De Buck R; De Frenne A; Dierick M; Linkowski P
    Acta Psychiatr Belg; 1992; 92(4):232-45. PubMed ID: 1345403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poststroke depression and fluoxetine.
    Stamenkovic M; Schindler S; Kasper S
    Am J Psychiatry; 1996 Mar; 153(3):446-7. PubMed ID: 8610848
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of fluoxetine in depression associated with multiple sclerosis.
    Shafey H
    Can J Psychiatry; 1992 Mar; 37(2):147-8. PubMed ID: 1562960
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-blind comparison of bupropion and fluoxetine in depressed outpatients.
    Feighner JP; Gardner EA; Johnston JA; Batey SR; Khayrallah MA; Ascher JA; Lineberry CG
    J Clin Psychiatry; 1991 Aug; 52(8):329-35. PubMed ID: 1907963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of low-dose fluoxetine in major depression and panic disorder.
    Louie AK; Lewis TB; Lannon RA
    J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dysfunctional attitudes in major depression. Changes with pharmacotherapy.
    Fava M; Bless E; Otto MW; Pava JA; Rosenbaum JF
    J Nerv Ment Dis; 1994 Jan; 182(1):45-9. PubMed ID: 8277301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Possible synergism between fluoxetine and lithium in refractory depression.
    Pope HG; McElroy SL; Nixon RA
    Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin for the treatment of sleep disturbances in major depressive disorder.
    Dolberg OT; Hirschmann S; Grunhaus L
    Am J Psychiatry; 1998 Aug; 155(8):1119-21. PubMed ID: 9699707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
    Cohn JB; Wilcox C
    J Clin Psychiatry; 1985 Mar; 46(3 Pt 2):26-31. PubMed ID: 3882677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Postpartum obsessive compulsive disorder: a case series.
    Sichel DA; Cohen LS; Dimmock JA; Rosenbaum JF
    J Clin Psychiatry; 1993 Apr; 54(4):156-9. PubMed ID: 8486594
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients.
    Heiligenstein JH; Faries DE; Rush AJ; Andersen JS; Pande AC; Roffwarg HP; Dunner D; Gillin JC; James SP; Lahmeyer H
    Psychiatry Res; 1994 Jun; 52(3):327-39. PubMed ID: 7991725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluoxetine versus trazodone: efficacy and activating-sedating effects.
    Beasley CM; Dornseif BE; Pultz JA; Bosomworth JC; Sayler ME
    J Clin Psychiatry; 1991 Jul; 52(7):294-9. PubMed ID: 2071559
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical studies of fluoxetine in depression.
    Int Clin Psychopharmacol; 1989 Jan; 4 Suppl 1():1-119. PubMed ID: 2644334
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of a refractory depression with a combination of fluoxetine and d-amphetamine.
    Linet LS
    Am J Psychiatry; 1989 Jun; 146(6):803-4. PubMed ID: 2786343
    [No Abstract]   [Full Text] [Related]  

  • 35. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of fluoxetine in depression associated with anabolic steroid withdrawal: a case series.
    Malone DA; Dimeff RJ
    J Clin Psychiatry; 1992 Apr; 53(4):130-2. PubMed ID: 1564048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal length of continuation therapy in depression: a prospective assessment during long-term fluoxetine treatment.
    Reimherr FW; Amsterdam JD; Quitkin FM; Rosenbaum JF; Fava M; Zajecka J; Beasley CM; Michelson D; Roback P; Sundell K
    Am J Psychiatry; 1998 Sep; 155(9):1247-53. PubMed ID: 9734550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personality disorder comorbidity with major depression and response to fluoxetine treatment.
    Fava M; Bouffides E; Pava JA; McCarthy MK; Steingard RJ; Rosenbaum JF
    Psychother Psychosom; 1994; 62(3-4):160-7. PubMed ID: 7846259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine: an alternative to the tricyclics in the treatment of major depression?
    Tacke U
    Am J Med Sci; 1989 Aug; 298(2):126-9. PubMed ID: 2669476
    [No Abstract]   [Full Text] [Related]  

  • 40. Fixed-dose fluoxetine therapy for depression.
    Wernicke JF; Dunlop SR; Dornseif BE; Zerbe RL
    Psychopharmacol Bull; 1987; 23(1):164-8. PubMed ID: 3496625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.